Structure and function of the AAA+ ATPase p97/Cdc48p

Gene

Volumn 583, Issue 1, 2016, Pages 64-77

  Xia, Di ^a   Tang, Wai Kwan ^a   Ye, Yihong ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

AAA+ ATPase; Chromatin associated degradation; ER associated degradation; Membrane fusion; Mitochondria associated degradation; P97 CDC48; Proteasome; Protein quality control; Ribosome associated degradation; Segregase; Ubiquitin; Unfoldase

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATE; ATAXIN 3; BORTEZOMIB; FAS ASSOCIATED FACTOR 1; GLYCOPEPTIDASE; NITROFURAN; PROTEIN CDC48P; PROTEIN P47; PROTEIN P97; UNCLASSIFIED DRUG; VALOSIN CONTAINING PROTEIN; CDC48 PROTEIN; CELL CYCLE PROTEIN; CHROMATIN;

AMYOTROPHIC LATERAL SCLEROSIS; APOPTOSIS; BIOLOGICAL FUNCTIONS; CANCER THERAPY; CARBOXY TERMINAL SEQUENCE; CHROMATIN; CONFORMATIONAL TRANSITION; CRYSTAL STRUCTURE; CRYSTALLIZATION; ENDOPLASMIC RETICULUM ASSOCIATED DEGRADATION; ENDOPLASMIC RETICULUM STRESS; FRONTOTEMPORAL DEMENTIA; GENETIC MANIPULATION; HUMAN; MEMBRANE FUSION; MEMBRANE VESICLE; NONHUMAN; NUCLEOTIDE BINDING SITE; PAGET BONE DISEASE; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN HOMEOSTASIS; PROTEIN HYDROLYSIS; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN STRUCTURE; PROTEIN UNFOLDING; REVIEW; SACCHAROMYCES CEREVISIAE; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMISTRY; GENETICS; HOMEOSTASIS; HYDROLYSIS; METABOLISM; MOLECULARLY TARGETED THERAPY; MOUSE; MUTATION; NEOPLASMS;

ADENOSINE TRIPHOSPHATASES; ADENOSINE TRIPHOSPHATE; ANIMALS; CELL CYCLE PROTEINS; CHROMATIN; HOMEOSTASIS; HUMANS; HYDROLYSIS; MEMBRANE FUSION; MICE; MOLECULAR TARGETED THERAPY; MUTATION; NEOPLASMS; PROTEIN CONFORMATION;

EID: 84963617847     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2016.02.042     Document Type: Review

References (153)

1. Acharya U., Jacobs R., Peters J.M., Watson N., Farquhar M.G., Malhotra V. The formation of Golgi stacks from vesiculated Golgi membranes requires two distinct fusion events. Cell 1995, 82:895-904.
2. Acs K., Luijsterburg M.S., Ackermann L., Salomons F.A., Hoppe T., Dantuma N.P. The AAA-ATPase VCP/p97 promotes 53BP1 recruitment by removing L3MBTL1 from DNA double-strand breaks. Nat. Struct. Mol. Biol. 2011, 18:1345-1350.
3. Allen M.D., Buchberger A., Bycroft M. The PUB domain functions as a p97 binding module in human peptide N-glycanase. J. Biol. Chem. 2006, 281:25502-25508.
4. Anderson D.J., Le Moigne R., Djakovic S., Kumar B., Rice J., Wong S., Wang J., Yao B., Valle E., Kiss von Soly S., Madriaga A., Soriano F., Menon M.K., Wu Z.Y., Kampmann M., Chen Y., Weissman J.S., Aftab B.T., Yakes F.M., Shawver L., Zhou H.J., Wustrow D., Rolfe M. Targeting the AAA ATPase p97 as an approach to treat cancer through disruption of protein homeostasis. Cancer Cell 2015, 28:653-665.
5. Ballar P., Shen Y., Yang H., Fang S. The role of a novel p97/valosin-containing protein-interacting motif of gp78 in endoplasmic reticulum-associated degradation. J. Biol. Chem. 2006, 281:35359-35368.
6. Ballar P., Zhong Y., Nagahama M., Tagaya M., Shen Y., Fang S. Identification of SVIP as an endogenous inhibitor of endoplasmic reticulum-associated degradation. J. Biol. Chem. 2007, 282:33908-33914.
7. Banerjee S., Bartesaghi A., Merk A., Rao P., Bulfer S.L., Yan Y., Green N., Mroczkowski B., Neitz R.J., Wipf P., Falconieri V., Deshaies R.J., Milne J.L., Huryn D., Arkin M., Subramaniam S. 2.3 A resolution cryo-EM structure of human p97 and mechanism of allosteric inhibition. Science 2016.
8. Barthelme D., Sauer R.T. Identification of the Cdc48*20S proteasome as an ancient AAA+ proteolytic machine. Science 2012, 337:843-846.
9. Barthelme D., Sauer R.T. Bipartite determinants mediate an evolutionarily conserved interaction between Cdc48 and the 20S peptidase. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:3327-3332.
10. Bays N.W., Wilhovsky S.K., Goradia A., Hodgkiss-Harlow K., Hampton R.Y. HRD4/NPL4 is required for the proteasomal processing of ubiquitinated ER proteins. Mol. Biol. Cell 2001, 12:4114-4128.
11. Bebeacua C., Forster A., McKeown C., Meyer H.H., Zhang X., Freemont P.S. Distinct conformations of the protein complex p97-Ufd1-Npl4 revealed by electron cryomicroscopy. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:1098-1103.
12. Bergink S., Ammon T., Kern M., Schermelleh L., Leonhardt H., Jentsch S. Role of Cdc48/p97 as a SUMO-targeted segregase curbing Rad51-Rad52 interaction. Nat. Cell Biol. 2013, 15:526-532.
13. Beskow A., Grimberg K.B., Bott L.C., Salomons F.A., Dantuma N.P., Young P. A conserved unfoldase activity for the p97 AAA-ATPase in proteasomal degradation. J. Mol. Biol. 2009, 394:732-746.
14. Beuron F., Flynn T.C., Ma J., Kondo H., Zhang X., Freemont P.S. Motions and negative cooperativity between p97 domains revealed by cryo-electron microscopy and quantised elastic deformational model. J. Mol. Biol. 2003, 327:619-629.
15. Beuron F., Dreveny I., Yuan X., Pye V.E., McKeown C., Briggs L.C., Cliff M.J., Kaneko Y., Wallis R., Isaacson R.L., Ladbury J.E., Matthews S.J., Kondo H., Zhang X., Freemont P.S. Conformational changes in the AAA ATPase p97-p47 adaptor complex. EMBO J. 2006, 25:1967-1976.
16. Blom D., Hirsch C., Stern P., Tortorella D., Ploegh H.L. A glycosylated type I membrane protein becomes cytosolic when peptide: N-glycanase is compromised. EMBO J. 2004, 23:650-658.
17. Boeddrich A., Gaumer S., Haacke A., Tzvetkov N., Albrecht M., Evert B.O., Muller E.C., Lurz R., Breuer P., Schugardt N., Plassmann S., Xu K., Warrick J.M., Suopanki J., Wullner U., Frank R., Hartl U.F., Bonini N.M., Wanker E.E. An arginine/lysine-rich motif is crucial for VCP/p97-mediated modulation of ataxin-3 fibrillogenesis. EMBO J. 2006, 25:1547-1558.
18. Bohm S., Lamberti G., Fernandez-Saiz V., Stapf C., Buchberger A. Cellular functions of Ufd2 and Ufd3 in proteasomal protein degradation depend on Cdc48 binding. Mol. Cell. Biol. 2011, 31:1528-1539.
19. Brandman O., Stewart-Ornstein J., Wong D., Larson A., Williams C.C., Li G.W., Zhou S., King D., Shen P.S., Weibezahn J., Dunn J.G., Rouskin S., Inada T., Frost A., Weissman J.S. A ribosome-bound quality control complex triggers degradation of nascent peptides and signals translation stress. Cell 2012, 151:1042-1054.
20. Braun S., Matuschewski K., Rape M., Thoms S., Jentsch S. Role of the ubiquitin-selective CDC48(UFD1/NPL4)chaperone (segregase) in ERAD of OLE1 and other substrates. EMBO J. 2002, 21:615-621.
21. Bruderer R.M., Brasseur C., Meyer H.H. The AAA ATPase p97/VCP interacts with its alternative co-factors, Ufd1-Npl4 and p47, through a common bipartite binding mechanism. J. Biol. Chem. 2004, 279:49609-49616.
22. Buchan J.R., Kolaitis R.M., Taylor J.P., Parker R. Eukaryotic stress granules are cleared by autophagy and Cdc48/VCP function. Cell 2013, 153:1461-1474.
23. Buchberger A., Schindelin H., Hanzelmann P. Control of p97 function by cofactor binding. FEBS Lett. 2015, 589:2578-2589.
24. Bug M., Meyer H. Expanding into new markets-VCP/p97 in endocytosis and autophagy. J. Struct. Biol. 2012, 179:78-82.
25. Carvalho P., Stanley A.M., Rapoport T.A. Retrotranslocation of a misfolded luminal ER protein by the ubiquitin-ligase Hrd1p. Cell 2010, 143:579-591.
26. Chou T.F., Brown S.J., Minond D., Nordin B.E., Li K., Jones A.C., Chase P., Porubsky P.R., Stoltz B.M., Schoenen F.J., Patricelli M.P., Hodder P., Rosen H., Deshaies R.J. Reversible inhibitor of p97, DBeQ, impairs both ubiquitin-dependent and autophagic protein clearance pathways. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:4834-4839.
27. Chou T.F., Li K., Frankowski K.J., Schoenen F.J., Deshaies R.J. Structure-activity relationship study reveals ML240 and ML241 as potent and selective inhibitors of p97 ATPase. ChemMedChem 2013, 8:297-312.
28. Chou T.F., Bulfer S.L., Weihl C.C., Li K., Lis L.G., Walters M.A., Schoenen F.J., Lin H.J., Deshaies R.J., Arkin M.R. Specific inhibition of p97/VCP ATPase and kinetic analysis demonstrate interaction between D1 and D2 ATPase domains. J. Mol. Biol. 2014, 426:2886-2899.
29. Christianson J.C., Ye Y. Cleaning up in the endoplasmic reticulum: ubiquitin in charge. Nat. Struct. Mol. Biol. 2014, 21:325-335.
30. Dantuma N.P., Hoppe T. Growing sphere of influence: Cdc48/p97 orchestrates ubiquitin-dependent extraction from chromatin. Trends Cell Biol. 2012, 22:483-491.
31. Dantuma N.P., Acs K., Luijsterburg M.S. Should I stay or should I go: VCP/p97-mediated chromatin extraction in the DNA damage response. Exp. Cell Res. 2014, 329:9-17.
32. Davies J.M., Tsuruta H., May A.P., Weis W.I. Conformational changes of p97 during nucleotide hydrolysis determined by small-angle X-ray scattering. Structure 2005, 13:183-195.
33. Davies J.M., Brunger A.T., Weis W.I. Improved structures of full-length p97, an AAA ATPase: implications for mechanisms of nucleotide-dependent conformational change. Structure 2008, 16:715-726.
34. Davis E.J., Lachaud C., Appleton P., Macartney T.J., Nathke I., Rouse J. DVC1 (C1orf124) recruits the p97 protein segregase to sites of DNA damage. Nat. Struct. Mol. Biol. 2012, 19:1093-1100.
35. Defenouillere Q., Yao Y., Mouaikel J., Namane A., Galopier A., Decourty L., Doyen A., Malabat C., Saveanu C., Jacquier A., Fromont-Racine M. Cdc48-associated complex bound to 60S particles is required for the clearance of aberrant translation products. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:5046-5051.
36. DeLaBarre B., Brunger A.T. Complete structure of p97/valosin-containing protein reveals communication between nucleotide domains. Nat. Struct. Biol. 2003, 10:856-863.
37. DeLaBarre B., Brunger A.T. Nucleotide dependent motion and mechanism of action of p97/VCP. J. Mol. Biol. 2005, 347:437-452.
38. DeLaBarre B., Christianson J.C., Kopito R.R., Brunger A.T. Central pore residues mediate the p97/VCP activity required for ERAD. Mol. Cell 2006, 22:451-462.
39. Dreveny I., Kondo H., Uchiyama K., Shaw A., Zhang X., Freemont P.S. Structural basis of the interaction between the AAA ATPase p97/VCP and its adaptor protein p47. EMBO J. 2004, 23:1030-1039.
40. Ewens C.A., Panico S., Kloppsteck P., McKeown C., Ebong I.O., Robinson C., Zhang X., Freemont P.S. The p97-FAF1 protein complex reveals a common mode of p97 adaptor binding. J. Biol. Chem. 2014, 289:12077-12084.
41. Fiebiger E., Hirsch C., Vyas J.M., Gordon E., Ploegh H.L., Tortorella D. Dissection of the dislocation pathway for type I membrane proteins with a new small molecule inhibitor, eeyarestatin. Mol. Biol. Cell 2004, 15:1635-1646.
42. Flierman D., Ye Y., Dai M., Chau V., Rapoport T.A. Polyubiquitin serves as a recognition signal, rather than a ratcheting molecule, during retrotranslocation of proteins across the endoplasmic reticulum membrane. J. Biol. Chem. 2003, 278:34774-34782.
43. Franz A., Orth M., Pirson P.A., Sonneville R., Julian Blow J., Gartner A., Stemmann O., Hoppe T. CDC-48/p97 coordinates CDT-1 degradation with GINS chromatin dissociation to ensure faithful DNA replication. Mol. Cell 2011.
44. Franz A., Ackermann L., Hoppe T. Create and preserve: proteostasis in development and aging is governed by Cdc48/p97/VCP. Biochim. Biophys. Acta 2014, 1843:205-215.
45. Gallagher P.S., Clowes Candadai S.V., Gardner R.G. The requirement for Cdc48/p97 in nuclear protein quality control degradation depends on the substrate and correlates with substrate insolubility. J. Cell Sci. 2014, 127:1980-1991.
46. Garza R.M., Sato B.K., Hampton R.Y. In vitro analysis of Hrd1p-mediated retrotranslocation of its multispanning membrane substrate 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase. J. Biol. Chem. 2009, 284:14710-14722.
47. Gerega A., Rockel B., Peters J., Tamura T., Baumeister W., Zwickl P. VAT, the thermoplasma homolog of mammalian p97/VCP, is an N domain-regulated protein unfoldase. J. Biol. Chem. 2005, 280:42856-42862.
48. Gill J.S., Ghatei M.A., Domin J., Bloom S.R. The generation of valosin-like peptides from a precursor protein in vitro as an extraction artifact. Life Sci. 1989, 44:483-491.
49. Godderz D., Heinen C., Marchese F.P., Kurz T., Acs K., Dantuma N.P. Cdc48-independent proteasomal degradation coincides with a reduced need for ubiquitylation. Sci. Rep. 2015, 5:7615.
50. Greenblatt E.J., Olzmann J.A., Kopito R.R. Derlin-1 is a rhomboid pseudoprotease required for the dislocation of mutant alpha-1 antitrypsin from the endoplasmic reticulum. Nat. Struct. Mol. Biol. 2011, 18:1147-1152.
51. Halawani D., LeBlanc A.C., Rouiller I., Michnick S.W., Servant M.J., Latterich M. Hereditary inclusion body myopathy-linked p97/VCP mutations in the NH2 domain and the D1 ring modulate p97/VCP ATPase activity and D2 ring conformation. Mol. Cell. Biol. 2009, 29:4484-4494.
52. Hanzelmann P., Schindelin H. The structural and functional basis of the p97/valosin-containing protein (VCP)-interacting motif (VIM): mutually exclusive binding of cofactors to the N-terminal domain of p97. J. Biol. Chem. 2011, 286:38679-38690.
53. Hanzelmann P., Schindelin H. Characterization of an Additional Binding Surface on the p97 N-Terminal Domain Involved in Bipartite Cofactor Interactions. Structure 2016, 24:140-147.
54. Hanzelmann P., Schindelin H. Structural Basis of ATP Hydrolysis and Intersubunit Signaling in the AAA+ ATPase p97. Structure 2016, 24:127-139.
55. Hanzelmann P., Buchberger A., Schindelin H. Hierarchical binding of cofactors to the AAA ATPase p97. Structure 2011, 19:833-843.
56. Hemion C., Flammer J., Neutzner A. Quality control of oxidatively damaged mitochondrial proteins is mediated by p97 and the proteasome. Free Radic. Biol. Med. 2014, 75:121-128.
57. Heo J.M., Livnat-Levanon N., Taylor E.B., Jones K.T., Dephoure N., Ring J., Xie J., Brodsky J.L., Madeo F., Gygi S.P., Ashrafi K., Glickman M.H., Rutter J. A stress-responsive system for mitochondrial protein degradation. Mol. Cell 2010, 40:465-480.
58. Hitchcock A.L., Krebber H., Frietze S., Lin A., Latterich M., Silver P.A. The conserved npl4 protein complex mediates proteasome-dependent membrane-bound transcription factor activation. Mol. Biol. Cell 2001, 12:3226-3241.
59. Huyton T., Pye V.E., Briggs L.C., Flynn T.C., Beuron F., Kondo H., Ma J., Zhang X., Freemont P.S. The crystal structure of murine p97/VCP at 3.6 A. J. Struct. Biol. 2003, 144:337-348.
60. Isaacson R.L., Pye V.E., Simpson P., Meyer H.H., Zhang X., Freemont P.S., Matthews S. Detailed structural insights into the p97-Npl4-Ufd1 interface. J. Biol. Chem. 2007, 282:21361-21369.
61. Jarosch E., Taxis C., Volkwein C., Bordallo J., Finley D., Wolf D.H., Sommer T. Protein dislocation from the ER requires polyubiquitination and the AAA-ATPase Cdc48. Nat. Cell Biol. 2002, 4:134-139.
62. Johnson E.S., Ma P.C., Ota I.M., Varshavsky A. A proteolytic pathway that recognizes ubiquitin as a degradation signal. J. Biol. Chem. 1995, 270:17442-17456.
63. Johnson J.O., Mandrioli J., Benatar M., Abramzon Y., Van Deerlin V.M., Trojanowski J.Q., Gibbs J.R., Brunetti M., Gronka S., Wuu J., Ding J., McCluskey L., Martinez-Lage M., Falcone D., Hernandez D.G., Arepalli S., Chong S., Schymick J.C., Rothstein J., Landi F., Wang Y.D., Calvo A., Mora G., Sabatelli M., Monsurro M.R., Battistini S., Salvi F., Spataro R., Sola P., Borghero G., Consortium I., Galassi G., Scholz S.W., Taylor J.P., Restagno G., Chio A., Traynor B.J. Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron 2010, 68:857-864.
64. Ju J.S., Weihl C.C. p97/VCP at the intersection of the autophagy and the ubiquitin proteasome system. Autophagy 2010, 6:283-285.
65. Ju J.S., Fuentealba R.A., Miller S.E., Jackson E., Piwnica-Worms D., Baloh R.H., Weihl C.C. Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease. J. Cell Biol. 2009, 187:875-888.
66. Kim S.J., Kim E.E. Crystallization and preliminary X-ray crystallographic analysis of the complex between the N-D1 domain of VCP from Homo sapiens and the N domain of OTU1 from Saccharomyces cerevisiae. Acta Crystallogr. Sect. F: Struct. Biol. Cryst. Commun. 2014, 70:1087-1089.
67. Kim K.H., Kang W., Suh S.W., Yang J.K. Crystal structure of FAF1 UBX domain in complex with p97/VCP N domain reveals a conformational change in the conserved FcisP touch-turn motif of UBX domain. Proteins 2011, 79:2583-2587.
68. Kimonis V.E., Watts G.D. Autosomal dominant inclusion body myopathy, Paget disease of bone, and frontotemporal dementia. Alzheimer Dis. Assoc. Disord. 2005, 19(Suppl. 1):S44-S47.
69. Kimonis V.E., Kovach M.J., Waggoner B., Leal S., Salam A., Rimer L., Davis K., Khardori R., Gelber D. Clinical and molecular studies in a unique family with autosomal dominant limb-girdle muscular dystrophy and Paget disease of bone. Genet. Med. 2000, 2:232-241.
70. Kimura Y., Fukushi J., Hori S., Matsuda N., Okatsu K., Kakiyama Y., Kawawaki J., Kakizuka A., Tanaka K. Different dynamic movements of wild-type and pathogenic VCPs and their cofactors to damaged mitochondria in a Parkin-mediated mitochondrial quality control system. Genes Cells 2013, 18:1131-1143.
71. Kirchner P., Bug M., Meyer H. Ubiquitination of the N-terminal region of caveolin-1 regulates endosomal sorting by the VCP/p97 AAA-ATPase. J. Biol. Chem. 2013, 288:7363-7372.
72. Koller K.J., Brownstein M.J. Use of a cDNA clone to identify a supposed precursor protein containing valosin. Nature 1987, 325:542-545.
73. Kondo H., Rabouille C., Newman R., Levine T.P., Pappin D., Freemont P., Warren G. p47 is a cofactor for p97-mediated membrane fusion. Nature 1997, 388:75-78.
74. Krick R., Bremer S., Welter E., Schlotterhose P., Muehe Y., Eskelinen E.L., Thumm M. Cdc48/p97 and Shp1/p47 regulate autophagosome biogenesis in concert with ubiquitin-like Atg8. J. Cell Biol. 2010, 190:965-973.
75. Latterich M., Frohlich K.U., Schekman R. Membrane fusion and the cell cycle: Cdc48p participates in the fusion of ER membranes. Cell 1995, 82:885-893.
76. Lee J.J., Park J.K., Jeong J., Jeon H., Yoon J.B., Kim E.E., Lee K.J. Complex of Fas-associated factor 1 (FAF1) with valosin-containing protein (VCP)-Npl4-Ufd1 and polyubiquitinated proteins promotes endoplasmic reticulum-associated degradation (ERAD). J. Biol. Chem. 2013, 288:6998-7011.
77. Lilley B.N., Ploegh H.L. A membrane protein required for dislocation of misfolded proteins from the ER. Nature 2004, 429:834-840.
78. Madeo F., Schlauer J., Zischka H., Mecke D., Frohlich K.U. Tyrosine phosphorylation regulates cell cycle-dependent nuclear localization of Cdc48p. Mol. Biol. Cell 1998, 9:131-141.
79. Magnaghi P., D'Alessio R., Valsasina B., Avanzi N., Rizzi S., Asa D., Gasparri F., Cozzi L., Cucchi U., Orrenius C., Polucci P., Ballinari D., Perrera C., Leone A., Cervi G., Casale E., Xiao Y., Wong C., Anderson D.J., Galvani A., Donati D., O'Brien T., Jackson P.K., Isacchi A. Covalent and allosteric inhibitors of the ATPase VCP/p97 induce cancer cell death. Nat. Chem. Biol. 2013, 9:548-556.
80. Maric M., Maculins T., De Piccoli G., Labib K. Cdc48 and a ubiquitin ligase drive disassembly of the CMG helicase at the end of DNA replication. Science 2014, 346:1253596.
81. Mehta S.G., Khare M., Ramani R., Watts G.D., Simon M., Osann K.E., Donkervoort S., Dec E., Nalbandian A., Platt J., Pasquali M., Wang A., Mozaffar T., Smith C.D., Kimonis V.E. Genotype-phenotype studies of VCP-associated inclusion body myopathy with Paget disease of bone and/or frontotemporal dementia. Clin. Genet. 2013, 83:422-431.
82. Meyer H., Weihl C.C. The VCP/p97 system at a glance: connecting cellular function to disease pathogenesis. J. Cell Sci. 2014, 127:3877-3883.
83. Meyer H.H., Kondo H., Warren G. The p47 co-factor regulates the ATPase activity of the membrane fusion protein, p97. FEBS Lett. 1998, 437:255-257.
84. Meyer H.H., Shorter J.G., Seemann J., Pappin D., Warren G. A complex of mammalian ufd1 and npl4 links the AAA-ATPase, p97, to ubiquitin and nuclear transport pathways. EMBO J. 2000, 19:2181-2192.
85. Meyer H.H., Wang Y., Warren G. Direct binding of ubiquitin conjugates by the mammalian p97 adaptor complexes, p47 and Ufd1-Npl4. EMBO J. 2002, 21:5645-5652.
86. Meyer H., Bug M., Bremer S. Emerging functions of the VCP/p97 AAA-ATPase in the ubiquitin system. Nat. Cell Biol. 2012, 14:117-123.
87. Moir D., Stewart S.E., Osmond B.C., Botstein D. Cold-sensitive cell-division-cycle mutants of yeast: isolation, properties, and pseudoreversion studies. Genetics 1982, 100:547-563.
88. Moreno S.P., Bailey R., Campion N., Herron S., Gambus A. Polyubiquitylation drives replisome disassembly at the termination of DNA replication. Science 2014, 346:477-481.
89. Mosbech A., Gibbs-Seymour I., Kagias K., Thorslund T., Beli P., Povlsen L., Nielsen S.V., Smedegaard S., Sedgwick G., Lukas C., Hartmann-Petersen R., Lukas J., Choudhary C., Pocock R., Bekker-Jensen S., Mailand N. DVC1 (C1orf124) is a DNA damage-targeting p97 adaptor that promotes ubiquitin-dependent responses to replication blocks. Nat. Struct. Mol. Biol. 2012, 19:1084-1092.
90. Murayama Y., Ogura T., Yamanaka K. Characterization of C-terminal adaptors, UFD-2 and UFD-3, of CDC-48 on the polyglutamine aggregation in C. elegans. Biochem. Biophys. Res. Commun. 2015, 459:154-160.
91. Nalbandian A., Donkervoort S., Dec E., Badadani M., Katheria V., Rana P., Nguyen C., Mukherjee J., Caiozzo V., Martin B., Watts G.D., Vesa J., Smith C., Kimonis V.E. The multiple faces of valosin-containing protein-associated diseases: inclusion body myopathy with Paget's disease of bone, frontotemporal dementia, and amyotrophic lateral sclerosis. J. Mol. Neurosci. 2011, 45:522-531.
92. Neuber O., Jarosch E., Volkwein C., Walter J., Sommer T. Ubx2 links the Cdc48 complex to ER-associated protein degradation. Nat. Cell Biol. 2005, 7:993-998.
93. Nishikori S., Esaki M., Yamanaka K., Sugimoto S., Ogura T. Positive cooperativity of the p97 AAA ATPase is critical for essential functions. J. Biol. Chem. 2011, 286:15815-15820.
94. Niwa H., Ewens C.A., Tsang C., Yeung H.O., Zhang X., Freemont P.S. The role of the N-domain in the ATPase activity of the mammalian AAA ATPase p97/VCP. J. Biol. Chem. 2012, 287:8561-8570.
95. Ogura T., Wilkinson A.J. AAA+ superfamily ATPases: common structure-diverse function. Genes Cells 2001, 6:575-597.
96. Peters J.M., Walsh M.J., Franke W.W. An abundant and ubiquitous homo-oligomeric ring-shaped ATPase particle related to the putative vesicle fusion proteins Sec18p and NSF. EMBO J. 1990, 9:1757-1767.
97. Puumalainen M.R., Lessel D., Ruthemann P., Kaczmarek N., Bachmann K., Ramadan K., Naegeli H. Chromatin retention of DNA damage sensors DDB2 and XPC through loss of p97 segregase causes genotoxicity. Nat. Commun. 2014, 5:3695.
98. Pye V.E., Dreveny I., Briggs L.C., Sands C., Beuron F., Zhang X., Freemont P.S. Going through the motions: the ATPase cycle of p97. J. Struct. Biol. 2006, 156:12-28.
99. Pye V.E., Beuron F., Keetch C.A., McKeown C., Robinson C.V., Meyer H.H., Zhang X., Freemont P.S. Structural insights into the p97-Ufd1-Npl4 complex. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:467-472.
100. Qiu L., Pashkova N., Walker J.R., Winistorfer S., Allali-Hassani A., Akutsu M., Piper R., Dhe-Paganon S. Structure and function of the PLAA/Ufd3-p97/Cdc48 complex. J. Biol. Chem. 2010, 285:365-372.
101. Rabinovich E., Kerem A., Frohlich K.U., Diamant N., Bar-Nun S. AAA-ATPase p97/Cdc48p, a cytosolic chaperone required for endoplasmic reticulum-associated protein degradation. Mol. Cell. Biol. 2002, 22:626-634.
102. Rabouille C., Levine T.P., Peters J.M., Warren G. An NSF-like ATPase, p97, and NSF mediate cisternal regrowth from mitotic Golgi fragments. Cell 1995, 82:905-914.
103. Radhakrishnan S.K., den Besten W., Deshaies R.J. p97-dependent retrotranslocation and proteolytic processing govern formation of active Nrf1 upon proteasome inhibition. eLife 2014, 3.
104. Ramadan K., Bruderer R., Spiga F.M., Popp O., Baur T., Gotta M., Meyer H.H. Cdc48/p97 promotes reformation of the nucleus by extracting the kinase Aurora B from chromatin. Nature 2007, 450:1258-1262.
105. Raman M., Havens C.G., Walter J.C., Harper J.W. A genome wide screen identifies p97 as an essential regulator of DNA damage-dependent CDT1 destruction. Mol. Cell 2011.
106. Ramanathan H.N., Ye Y. The p97 ATPase associates with EEA1 to regulate the size of early endosomes. Cell Res. 2012, 22:346-359.
107. Rape M., Hoppe T., Gorr I., Kalocay M., Richly H., Jentsch S. Mobilization of processed, membrane-tethered SPT23 transcription factor by CDC48(UFD1/NPL4), a ubiquitin-selective chaperone. Cell 2001, 107:667-677.
108. Ritz D., Vuk M., Kirchner P., Bug M., Schutz S., Hayer A., Bremer S., Lusk C., Baloh R.H., Lee H., Glatter T., Gstaiger M., Aebersold R., Weihl C.C., Meyer H. Endolysosomal sorting of ubiquitylated caveolin-1 is regulated by VCP and UBXD1 and impaired by VCP disease mutations. Nat. Cell Biol. 2011, 13:1116-1123.
109. Rothballer A., Tzvetkov N., Zwickl P. Mutations in p97/VCP induce unfolding activity. FEBS Lett. 2007, 581:1197-1201.
110. Rouiller I., Butel V.M., Latterich M., Milligan R.A., Wilson-Kubalek E.M. A major conformational change in p97 AAA ATPase upon ATP binding. Mol. Cell 2000, 6:1485-1490.
111. Rouiller I., DeLaBarre B., May A.P., Weis W.I., Brunger A.T., Milligan R.A., Wilson-Kubalek E.M. Conformational changes of the multifunction p97 AAA ATPase during its ATPase cycle. Nat. Struct. Biol. 2002, 9:950-957.
112. Ruggiano A., Foresti O., Carvalho P. Quality control: ER-associated degradation: protein quality control and beyond. J. Cell Biol. 2014, 204:869-879.
113. Rumpf S., Jentsch S. Functional division of substrate processing cofactors of the ubiquitin-selective Cdc48 chaperone. Mol. Cell 2006, 21:261-269.
114. Schaeffer V., Akutsu M., Olma M.H., Gomes L.C., Kawasaki M., Dikic I. Binding of OTULIN to the PUB domain of HOIP controls NF-kappaB signaling. Mol. Cell 2014, 54:349-361.
115. Schuberth C., Buchberger A. Membrane-bound Ubx2 recruits Cdc48 to ubiquitin ligases and their substrates to ensure efficient ER-associated protein degradation. Nat. Cell Biol. 2005, 7:999-1006.
116. Schuberth C., Buchberger A. UBX domain proteins: major regulators of the AAA ATPase Cdc48/p97. Cell. Mol. Life Sci. 2008, 65:2360-2371.
117. Schuller J.M., Beck F., Lossl P., Heck A.J., Forster F. Nucleotide-dependent conformational changes of the AAA+ ATPase p97 revisited. FEBS Lett. 2016.
118. Shcherbik N., Haines D.S. Cdc48p(Npl4p/Ufd1p) binds and segregates membrane-anchored/tethered complexes via a polyubiquitin signal present on the anchors. Mol. Cell 2007, 25:385-397.
119. Singh S.K., Grimaud R., Hoskins J.R., Wickner S., Maurizi M.R. Unfolding and internalization of proteins by the ATP-dependent proteases ClpXP and ClpAP. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:8898-8903.
120. Smith M.H., Ploegh H.L., Weissman J.S. Road to ruin: targeting proteins for degradation in the endoplasmic reticulum. Science 2011, 334:1086-1090.
121. Song C., Wang Q., Li C.C. ATPase activity of p97-valosin-containing protein (VCP). D2 mediates the major enzyme activity, and D1 contributes to the heat-induced activity. J. Biol. Chem. 2003, 278:3648-3655.
122. Stapf C., Cartwright E., Bycroft M., Hofmann K., Buchberger A. The general definition of the p97/valosin-containing protein (VCP)-interacting motif (VIM) delineates a new family of p97 cofactors. J. Biol. Chem. 2011, 286:38670-38678.
123. Tanaka A., Cleland M.M., Xu S., Narendra D.P., Suen D.F., Karbowski M., Youle R.J. Proteasome and p97 mediate mitophagy and degradation of mitofusins induced by Parkin. J. Cell Biol. 2010, 191:1367-1380.
124. Tang W.K., Xia D. Structural and functional deviations in disease-associated p97 mutants. J. Struct. Biol. 2012, 179:83-92.
125. Tang W.K., Xia D. Altered intersubunit communication is the molecular basis for functional defects of pathogenic p97 mutants. J. Biol. Chem. 2013, 288:36624-36635.
126. Tang W.K., Xia D. Role of the D1-D2 linker of human VCP/p97 in the asymmetry and ATPase activity of the D1-domain. Sci. Rep. 2016, 6:20037.
127. Tang W.K., Li D., Li C.C., Esser L., Dai R., Guo L., Xia D. A novel ATP-dependent conformation in p97 N-D1 fragment revealed by crystal structures of disease-related mutants. EMBO J. 2010, 29:2217-2229.
128. Uchiyama K., Kondo H. p97/p47-mediated biogenesis of Golgi and ER. J. Biochem. 2005, 137:115-119.
129. Uchiyama K., Jokitalo E., Kano F., Murata M., Zhang X., Canas B., Newman R., Rabouille C., Pappin D., Freemont P., Kondo H. VCIP135, a novel essential factor for p97/p47-mediated membrane fusion, is required for Golgi and ER assembly in vivo. J. Cell Biol. 2002, 159:855-866.
130. Uchiyama K., Totsukawa G., Puhka M., Kaneko Y., Jokitalo E., Dreveny I., Beuron F., Zhang X., Freemont P., Kondo H. p37 is a p97 adaptor required for Golgi and ER biogenesis in interphase and at the end of mitosis. Dev. Cell 2006, 11:803-816.
131. Verma R., Oania R., Fang R., Smith G.T., Deshaies R.J. Cdc48/p97 mediates UV-dependent turnover of RNA Pol II. Mol. Cell 2011, 41:82-92.
132. Verma R., Oania R.S., Kolawa N.J., Deshaies R.J. Cdc48/p97 promotes degradation of aberrant nascent polypeptides bound to the ribosome. eLife 2013, 2.
133. Wang Q., Song C., Yang X., Li C.C. D1 ring is stable and nucleotide-independent, whereas D2 ring undergoes major conformational changes during the ATPase cycle of p97-VCP. J. Biol. Chem. 2003, 278:32784-32793.
134. Wang Q., Li L., Ye Y. Inhibition of p97-dependent protein degradation by Eeyarestatin I. J. Biol. Chem. 2008.
135. Wang Q., Mora-Jensen H., Weniger M.A., Perez-Galan P., Wolford C., Hai T., Ron D., Chen W., Trenkle W., Wiestner A., Ye Y. ERAD inhibitors integrate ER stress with an epigenetic mechanism to activate BH3-only protein NOXA in cancer cells. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:2200-2205.
136. Wang Q., Shinkre B.A., Lee J.G., Weniger M.A., Liu Y., Chen W., Wiestner A., Trenkle W.C., Ye Y. The ERAD inhibitor Eeyarestatin I is a bifunctional compound with a membrane-binding domain and a p97/VCP inhibitory group. PLoS One 2010, 5.
137. Watts G.D., Wymer J., Kovach M.J., Mehta S.G., Mumm S., Darvish D., Pestronk A., Whyte M.P., Kimonis V.E. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat. Genet. 2004, 36:377-381.
138. Weihl C.C., Dalal S., Pestronk A., Hanson P.I. Inclusion body myopathy-associated mutations in p97/VCP impair endoplasmic reticulum-associated degradation. Hum. Mol. Genet. 2006, 15:189-199.
139. Weihl C.C., Temiz P., Miller S.E., Watts G., Smith C., Forman M., Hanson P.I., Kimonis V., Pestronk A. TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia. J. Neurol. Neurosurg. Psychiatry 2008, 79:1186-1189.
140. Wilcox A.J., Laney J.D. A ubiquitin-selective AAA-ATPase mediates transcriptional switching by remodelling a repressor-promoter DNA complex. Nat. Cell Biol. 2009, 11:1481-1486.
141. Xu S., Peng G., Wang Y., Fang S., Karbowski M. The AAA-ATPase p97 is essential for outer mitochondrial membrane protein turnover. Mol. Biol. Cell 2011, 22:291-300.
142. Yamanaka K., Sasagawa Y., Ogura T. Recent advances in p97/VCP/Cdc48 cellular functions. Biochim. Biophys. Acta 2012, 1823:130-137.
143. Ye Y. Diverse functions with a common regulator: ubiquitin takes command of an AAA ATPase. J. Struct. Biol. 2006, 156:29-40.
144. Ye Y., Meyer H.H., Rapoport T.A. The AAA ATPase Cdc48/p97 and its partners transport proteins from the ER into the cytosol. Nature 2001, 414:652-656.
145. Ye Y., Meyer H.H., Rapoport T.A. Function of the p97-Ufd1-Npl4 complex in retrotranslocation from the ER to the cytosol: dual recognition of nonubiquitinated polypeptide segments and polyubiquitin chains. J. Cell Biol. 2003, 162:71-84.
146. Ye Y., Shibata Y., Yun C., Ron D., Rapoport T.A. A membrane protein complex mediates retro-translocation from the ER lumen into the cytosol. Nature 2004, 429:841-847.
147. Zhang T., Ye Y. The final moments of misfolded proteins en route to the proteasome. DNA Cell Biol. 2014, 33:477-483.
148. Zhang L., Ashendel C.L., Becker G.W., Morre D.J. Isolation and characterization of the principal ATPase associated with transitional endoplasmic reticulum of rat liver. J. Cell Biol. 1994, 127:1871-1883.
149. Zhang X., Shaw A., Bates P.A., Newman R.H., Gowen B., Orlova E., Gorman M.A., Kondo H., Dokurno P., Lally J., Leonard G., Meyer H., van Heel M., Freemont P.S. Structure of the AAA ATPase p97. Mol. Cell 2000, 6:1473-1484.
150. Zhang X., Gui L., Zhang X., Bulfer S.L., Sanghez V., Wong D.E., Lee Y., Lehmann L., Lee J.S., Shih P.Y., Lin H.J., Iacovino M., Weihl C.C., Arkin M.R., Wang Y., Chou T.F. Altered cofactor regulation with disease-associated p97/VCP mutations. Proc. Natl. Acad. Sci. U. S. A. 2015, 112:E1705-E1714.
151. Zhao G., Zhou X., Wang L., Li G., Schindelin H., Lennarz W.J. Studies on peptide:N-glycanase-p97 interaction suggest that p97 phosphorylation modulates endoplasmic reticulum-associated degradation. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:8785-8790.
152. Zhong X., Shen Y., Ballar P., Apostolou A., Agami R., Fang S. AAA ATPase p97/valosin-containing protein interacts with gp78, a ubiquitin ligase for endoplasmic reticulum-associated degradation. J. Biol. Chem. 2004, 279:45676-45684.
153. Zhou H.J., Wang J., Yao B., Wong S., Djakovic S., Kumar B., Rice J., Valle E., Soriano F., Menon M.K., Madriaga A., Kissvonsoly S., Kumar A., Parlati F., Yakes M.F., Shawver L., Le Moigne R., Anderson D.J., Rolfe M., Wustrow D. Discovery of a first-in-class, potent, selective and orally bioavailable inhibitor of the p97 AAA ATPase (CB-5083). J. Med. Chem. 2015.